Colangite aguda

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 13 Nov 2025
Last updated: 18 Jul 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • dor no quadrante superior direito/dor na parte superior do abdômen
  • sensibilidade no quadrante superior direito/na parte superior do abdome
  • icterícia
  • febre
Full details

Other diagnostic factors

  • fezes claras
  • prurido
  • hipotensão
  • alterações do estado mental
Full details

Risk factors

  • idade >50 anos
  • colelitíase
  • estenose benigna
  • estenose maligna
  • lesão do ducto biliar pós-procedimento
  • história de colangite esclerosante primária
  • história de colangite esclerosante secundária
  • Infecção pelo vírus da imunodeficiência humana (HIV)
  • inibidores de checkpoints imunológicos
  • Doença relacionada à IgG4
Full details

Diagnostic investigations

1st investigations to order

  • Hemograma completo
  • ureia sérica
  • creatinina sérica
  • Análise da gasometria arterial
  • testes séricos da função hepática
  • proteína C-reativa
  • potássio sérico
  • magnésio sérico
  • hemoculturas
  • painel da coagulação
  • ultrassonografia transabdominal
Full details

Investigations to consider

  • tomografia computadorizada (TC) do abdome com contraste intravenoso
  • colangiopancreatografia retrógrada endoscópica (CPRE)
  • colangiopancreatografia por ressonância magnética (CPRM)
  • colangiografia trans-hepática percutânea (CTP)
  • ultrassonografia endoscópica (USE)
Full details

Treatment algorithm

ACUTE

agudamente doente

ONGOING

com coledocolitíase, colangite esclerosante primária ou colangiopatia por vírus da imunodeficiência humana (HIV)

Contributors

Expert advisers

Christian Macutkiewicz, MD, FHEA, FRCS

Consultant General & Hepato-Pancreato-Biliary (HPB) Surgeon

Manchester Royal Infirmary

Manchester

UK

Disclosures

CM declares that he has no competing interests.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributor, whose work has been retained in parts of the content:

Douglas G. Adler, MD, FACG, AGAF, FASGE

Professor of Medicine

Director

Center for Advanced Therapeutic Endoscopy (CATE)

Porter Adventist Hospital

Centura Health

Denver

CO

Disclosures: DGA has consulted for Boston Scientific, Merit Medical, and Olympus, who make endoscopic retrograde cholangio-pancreatography (ERCP) products, and has also consulted for AbbVie Pharmaceuticals. He is an author of references cited in this topic.

Revisores

David J. Hackam, MD, PhD

Associate Professor of Pediatric Surgery

University of Pittsburgh School of Medicine

Pittsburgh

PA

Declarações

DJH declares that he has no competing interests.

Todd Baron, MD

Professor of Medicine

Division of Gastroenterology & Hepatology

Mayo Clinic Rochester

Rochester

MN

Declarações

TB declares that he has no competing interests.

Dennis Freshwater, MB, BS, MD, FRCP

Consultant Hepatologist

The Liver and Hepatobiliary Unit

Queen Elizabeth Medical Care Unit

University Hospitals Birmingham NHS Foundation Trust

Birmingham

UK

Declarações

DF declares that he has no competing interests.

Bertus Eksteen, MRCP, PhD, MRC

Clinical Scientist

University of Birmingham

Honorary Consultant

Liver Transplant Unit

University Hospitals Birmingham NHS Foundation Trust

Birmingham

UK

Declarações

BE declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Kiriyama S, Kozaka K, Takada T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):17-30.Texto completo  Resumo

Miura F, Okamoto K, Takada T, et al. Tokyo guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40.Texto completo  Resumo

National Institute for Health and Care Excellence. Gallstone disease: diagnosis and management. October 2014 [internet publication].Texto completo

Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.Texto completo  Resumo

Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):537-49.Texto completo  Resumo

Artigos de referência

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Colangite aguda images
  • Differentials

    • Colecistite aguda
    • Úlcera péptica
    • Pancreatite aguda
    More Differentials
  • Guidelines

    • ACG clinical guideline: diagnosis and management of biliary strictures
    • ASGE guideline on the management of cholangitis
    More Guidelines
  • Videos

    Venopunção e flebotomia – Vídeo de demonstração

    Canulação venosa periférica – Vídeo de demonstração

    More videos
  • Patient information

    Cálculos biliares

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer